5NXS image
Entry Detail
PDB ID:
5NXS
Title:
Crystal Structure of Human Pro-myostatin Precursor at 4.2 A Resolution with Experimental Phases from SeMet labelling
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2017-05-10
Release Date:
2018-01-17
Method Details:
Experimental Method:
Resolution:
4.19 Å
R-Value Free:
0.30
R-Value Work:
0.27
R-Value Observed:
0.27
Space Group:
I 2 3
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Growth/differentiation factor 8
Mutations:deltaN25
Chain IDs:A, B
Chain Length:335
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MSE A MET modified residue
Ligand Molecules
Primary Citation
Structure of the human myostatin precursor and determinants of growth factor latency.
EMBO J. 37 367 383 (2018)
PMID: 29330193 DOI: 10.15252/embj.201797883

Abstact

Myostatin, a key regulator of muscle mass in vertebrates, is biosynthesised as a latent precursor in muscle and is activated by sequential proteolysis of the pro-domain. To investigate the molecular mechanism by which pro-myostatin remains latent, we have determined the structure of unprocessed pro-myostatin and analysed the properties of the protein in its different forms. Crystal structures and SAXS analyses show that pro-myostatin adopts an open, V-shaped structure with a domain-swapped arrangement. The pro-mature complex, after cleavage of the furin site, has significantly reduced activity compared with the mature growth factor and persists as a stable complex that is resistant to the natural antagonist follistatin. The latency appears to be conferred by a number of distinct features that collectively stabilise the interaction of the pro-domains with the mature growth factor, enabling a regulated stepwise activation process, distinct from the prototypical pro-TGF-β1. These results provide a basis for understanding the effect of missense mutations in pro-myostatin and pave the way for the design of novel myostatin inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures